-
UConn Health Seeking Seniors for Trial Study on Drug to Fight COVID-19 in Older Adults
UConn Health is trying to fight the impacts of COVID-19 on senior citizens by studying a drug that could improve the overall health of people over age 65. “The vulnerability of older adults to severe COVID is really striking,” said Dr. George Kuchel, director of the UConn Center on Aging. Kuchel is a doctor of geriatric medicine at UConn Health,…
-
Everything You Need to Know About the Moderna and Pfizer COVID-19 Vaccines
Moderna and Pfizer have now both reported that their COVID-19 vaccines have been highly effective in trials. But how do they work, and what are the differences between the two? Benjamin Neuman, a professor of biological studies at Texas A&M, breaks down the specifics of both vaccines.
-
‘It Could Really Save Lives:' Blood Plasma Donations Urged
There has been a major step forward in the effort to potentially save the lives of those critically sick with COVID-19. Several patients at hospitals in the state have begun treatment with blood plasma donated by those who successfully fought the virus. “We’ve been symptom free and you know recovered for a few weeks now,” said Shawna Edwards. Edwards...
-
Antibodies From Recovered COVID-19 Patients Could Help Critically Sick
A new potential way to help people fight the coronavirus is being studied in Connecticut.
-
Antibodies From Recovered COVID-19 Patients Could Help Critically Sick
The U.S. Food and Drug Administration approved a clinical trial at four health systems in the country, including at Trinity Health of New England, to investigate if blood plasma therapy can help patients with COVID-19. “We’re very excited about this therapy,” said. Dr. Danyal Ibrahim of Trinity Health of New England. Soon the team will get antibodies from people...